Clinical Trial

HS-IT101 Injection for Advanced NSCLC

Name: HS-IT101 Injection for Advanced NSCLC — clinical trial record (NCT07105176)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

An Open-Label, Single-Arm Phase Ib Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HS-IT101 Injection in Subjects with Advanced NSCLC.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-29.

Trial Details

NCT Number	NCT07105176
Lead Sponsor	Qingdao Sino-Cell Biomedicine Co., Ltd.
Conditions	Advanced Non-Small Cell Lung Cancer
Enrollment	12 participants
Start Date	2025-08-30
Primary Completion	2026-08-30 (estimated)
Study Completion	2027-08-30 (estimated)
Updated on ClinicalTrials.gov	2025-08-19